Skip to main content
logo
Esperion Therapeutics, Inc. (ESPR)
NASDAQ: ESPR · Real-Time Price · USD
2.440
-0.030 (-1.21%)
At close: Mar 13, 2026, 4:00 PM EDT
2.519
+0.079 (3.22%)
After-hours: Mar 13, 2026, 7:59 PM EDT

Esperion Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-22.68-51.75-209.25-233.66-269.11
Depreciation & Amortization
0.110.060.160.50.61
Stock-Based Compensation
9.8711.9911.9615.2224.31
Other Adjustments
14.2676.5747.9646.4932.89
Change in Receivables
-60.05-31.65-14.77-10.8-10.55
Changes in Inventories
-10.63-28.87-30.42-0.81-18.26
Changes in Accounts Payable
20.9212.438.685.6-34.1
Changes in Accrued Expenses
31.2218.3422.14.026.93
Changes in Unearned Revenue
25.96-16.8821.9-2.814.66
Changes in Other Operating Activities
-22.06-13.96.191.42-1.19
Operating Cash Flow
-13.09-23.65-135.49-174.83-263.81
Capital Expenditures
--0.32---
Purchases of Investments
----59.9-50.48
Proceeds from Sale of Investments
--42.568-
Investing Cash Flow
--0.3242.58.1-50.48
Long-Term Debt Issued
-549.76--49.92
Long-Term Debt Repaid
-54.91-559.67-15.51-58.02-3.39
Net Long-Term Debt Issued (Repaid)
-54.91-9.91-15.51-58.0246.53
Issuance of Common Stock
98.35105.9965.9590.85222.45
Net Common Stock Issued (Repurchased)
98.35105.9965.9590.85222.45
Other Financing Activities
-7.26-9.60.02-0.22-0.76
Financing Cash Flow
36.1886.4850.4632.61268.22
Net Cash Flow
23.0962.51-42.53-134.12-46.07
Free Cash Flow
-13.09-23.97-135.49-174.83-263.81
FCF Margin
-3.25%-7.21%-116.46%-231.64%-336.29%
Free Cash Flow Per Share
-0.06-0.13-1.31-2.63-9.13
Levered Free Cash Flow
-32.08-90.79-196.15-283.76-263.94
Unlevered Free Cash Flow
111.1125.27-126.96-171.58-268.09
Updated Mar 10, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q